Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

Veoza, also known as fezolinetant, was first approved a couple of years ago - and is now available for prescription for those eligible ...

In the final draft guidance published today, NICE recommended the fezolinetant 45mg tablet for women experiencing moderate to ...

J&J gains EU approval to expand Akeega use to treat patients with BRCA-mutated metastatic hormone-sensitive prostate cancer.

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Better regulation and enforcement urged before launch of oral treatments, which criminals are likely to try to exploit Experts are warning that fake weight-loss treatments could become more prevalent ...

Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...

LAS VEGAS—At CES, a little-known Chinese company is pushing the boundaries of tablet design with a device that’s barely one-tenth of an inch thick. It's called the Paper, and at first glance, it ...

Tablets aren't (and probably never will be) as popular as smartphones — after all, they're not as portable and pocketable. However, they're pretty great devices in their own niche, and those who find ...

A frequently used blood pressure medication has been recalled due to concerns that it might be cross-contaminated with another drug. Glenmark Pharmaceuticals Inc. in the US has recalled over 11,100 ...

Happy Black Friday, everyone. Now, let’s see what’s good. Note that we have smartphone deals in a separate post. Here we will focus on the best tablet, laptop, smartwatch and other offers in the UK.

Print copy of The Tablet delivered directly to your door. Complete access to all Tablet website content including all premium content. Access to the weekly digital copy of The Tablet. Full access to ...